XWELL (NASDAQ:XWEL) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of XWELL (NASDAQ:XWEL) to a sell rating in a research note released on Saturday.

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of XWELL in a report on Wednesday, January 21st. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has an average rating of “Sell”.

XWELL Stock Performance

XWEL opened at $1.18 on Friday. XWELL has a one year low of $0.26 and a one year high of $2.20. The company has a market cap of $9.36 million, a P/E ratio of -0.23 and a beta of 0.96. The business’s 50-day simple moving average is $1.02 and its 200-day simple moving average is $0.84.

XWELL (NASDAQ:XWEL) last released its quarterly earnings results on Wednesday, April 1st. The company reported ($3.29) earnings per share (EPS) for the quarter. The firm had revenue of $7.15 million for the quarter. XWELL had a negative return on equity of 352.37% and a negative net margin of 58.17%.

About XWELL

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.